Channa Jayasena is a Clinical Senior Lecturer and Consultant in Reproductive Endocrinology and Andrology at Imperial College and Hammersmith Hospital, London. Dr. Jayasena qualified in medicine at Cambridge University, after which he undertook specialist training in Diabetes & Endocrinology in London. Having been awarded a Wellcome Trust Clinical Research Training Fellowship and NIHR Clinical Lectureship, he conducted first-to-human studies at Imperial College investigating the clinical effects of novel hypothalamic neuropeptides such as kisspeptin on the human reproductive axis of men and women. He is currently Clinical Lead for Male Infertility / Andrology at Hammersmith Hospital which has developed cutting edge techniques such as seminal reactive oxygen species (ROS) measurement, microsurgical testicular sperm extraction (mTESE) and testicular mapping.
Dr. Jayasena has recently been awarded an NIHR Post-Doctoral Fellowship investigating the metabolic regulation of male infertility. He is also Chief Investigator on an NIHR Health Technology Assessment (HTA) funded project to investigate the Efficacy and Safety of Testosterone Replacement in Men (TestES Consortium).
His current research focuses on developing novel diagnostics and therapeutics for men and women with disorders of reproduction.
For details of clinical services available, click this link.
et al., 2019, A systematic review of randomized controlled trials investigating the efficacy and safety of testosterone therapy for female sexual dysfunction in postmenopausal women, Clinical Endocrinology, Vol:90, ISSN:0300-0664, Pages:391-414
et al., 2019, Reduced Testicular Steroidogenesis and Increased Semen Oxidative Stress in Male Partners as Novel Markers of Recurrent Miscarriage, Clinical Chemistry, Vol:65, ISSN:0009-9147, Pages:161-169
et al., 2019, The effects of testosterone replacement therapy on the prostate: a clinical perspective., F1000res, Vol:8
et al., 2018, Detection of mutations in SF3B1, EIF1AX and GNAQ in primary orbital melanoma by candidate gene analysis, Bmc Cancer, Vol:18, ISSN:1471-2407
et al., 2018, Prevalence of abnormal semen analysis and levels of adherence with fertility preservation in men undergoing therapy for newly diagnosed cancer: A retrospective study in 2906 patients, Clinical Endocrinology, Vol:89, ISSN:0300-0664, Pages:798-804